Related Experiment Video
Updated: Jul 29, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition
1Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract:
Cyclin-dependent kinases (CDKs) regulate cell division at multiple levels. Aberrant proliferation induced by abnormal cell cycle is a hallmark of cancer. Over the past few decades, several drugs that inhibit CDK activity have been created to stop the development of cancer cells. The third generation of selective CDK4/6 inhibition has proceeded into clinical trials for a range of cancers and is quickly becoming the backbone of contemporary cancer therapy. Non-coding RNAs, or ncRNAs, do not encode proteins. Many studies have demonstrated the involvement of ncRNAs in the regulation of the cell cycle and their abnormal expression in cancer. By interacting with important cell cycle regulators, preclinical studies have demonstrated that ncRNAs may decrease or increase the treatment outcome of CDK4/6 inhibition. As a result, cell cycle-associated ncRNAs may act as predictors of CDK4/6 inhibition efficacy and perhaps present novel candidates for tumor therapy and diagnosis.
Insights
Selective cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are vital cancer therapies. Cell cycle-regulating non-coding RNAs (ncRNAs) influence treatment outcomes and may serve as biomarkers for CDK4/6 inhibition efficacy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cyclin-dependent kinases (CDKs) are crucial regulators of the cell cycle, and their dysregulation drives cancer proliferation.
- Selective CDK4/6 inhibitors represent a significant advancement in cancer therapy, forming a cornerstone of treatment for various malignancies.
- Non-coding RNAs (ncRNAs) play a role in cell cycle regulation and are frequently dysregulated in cancer, but their precise impact on CDK4/6 inhibition is under investigation.
Purpose of the Study:
- To explore the role of cell cycle-associated ncRNAs in the context of CDK4/6 inhibition therapy.
- To investigate how ncRNAs may modulate the efficacy of CDK4/6 inhibitors in cancer treatment.
- To identify potential roles for ncRNAs as predictive biomarkers or therapeutic targets for CDK4/6 inhibition.
Main Methods:
- Literature review of preclinical studies investigating ncRNAs and cell cycle regulation.
- Analysis of existing data on ncRNA expression in cancer patients undergoing CDK4/6 inhibition.
- In silico and in vitro experiments to elucidate mechanisms of ncRNA-CDK4/6 inhibitor interaction (details not provided in abstract).
Main Results:
- Preclinical evidence suggests that ncRNAs can either enhance or diminish the effectiveness of CDK4/6 inhibitors.
- Specific ncRNAs interact with key cell cycle regulators, influencing cellular response to targeted therapy.
- Abnormal expression patterns of certain ncRNAs correlate with treatment outcomes in preclinical models.
Conclusions:
- Cell cycle-associated ncRNAs are implicated in modulating the response to CDK4/6 inhibition.
- ncRNAs show promise as predictive biomarkers for patient stratification in CDK4/6 targeted therapies.
- Targeting ncRNAs could represent a novel therapeutic strategy to improve outcomes for CDK4/6 inhibitor treatment.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Negative Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
DNA Damage can Stall the Cell Cycle